Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029149
Filing Date
2025-02-27
Accepted
2025-02-27 16:39:25
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xene-20241231.htm   iXBRL 10-K 3721496
2 EX-4.3 xene-ex4_3.htm EX-4.3 48259
3 EX-10.30 xene-ex10_30.htm EX-10.30 82768
4 EX-10.31 xene-ex10_31.htm EX-10.31 59493
5 EX-10.32 xene-ex10_32.htm EX-10.32 512082
6 EX-10.33 xene-ex10_33.htm EX-10.33 57482
7 EX-19 xene-ex19.htm EX-19 206508
8 EX-23.1 xene-ex23_1.htm EX-23.1 6799
9 EX-31.1 xene-ex31_1.htm EX-31.1 14316
10 EX-31.2 xene-ex31_2.htm EX-31.2 13971
11 EX-32.1 xene-ex32_1.htm EX-32.1 11289
12 EX-32.2 xene-ex32_2.htm EX-32.2 10966
13 GRAPHIC img255015816_0.jpg GRAPHIC 1105508
14 GRAPHIC img255015816_1.jpg GRAPHIC 295008
  Complete submission text file 0000950170-25-029149.txt   16763145

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20241231.xsd EX-101.SCH 1382659
92 EXTRACTED XBRL INSTANCE DOCUMENT xene-20241231_htm.xml XML 2324916
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36687 | Film No.: 25679892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)